Ampio Pharmaceuticals, Inc. (AMPE)

OTCMKTS · Delayed Price · Currency is USD
0.293
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
48,658%
Market Cap 332.15K
Revenue (ttm) n/a
Net Income (ttm) -8.63M
Shares Out 1.14M
EPS (ttm) -10.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 334
Average Volume 1,423
Open 0.005
Previous Close 0.293
Day's Range 0.005 - 0.293
52-Week Range 0.000 - 0.293
Beta 7.16
RSI 66.88
Earnings Date n/a

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Michael Martino
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol AMPE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.